CoChat

Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies

Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., Vinken, M. · 2013 · Archives of Toxicology

The DOI matches its Crossref record; 423 of the 423 references it cites were found in a registry or an index.

Abstract

Continuously increasing understanding of the molecular triggers responsible for the onset of diseases, paralleled by an equally dynamic evolution of chemical synthesis and screening methods, offers an abundance of pharmacological agents with a potential to become new successful drugs. However, before patients can benefit of newly developed pharmaceuticals, stringent safety filters need to be applied to weed out unfavourable drug candidates. Cost effectiveness and the need to identify compound liabilities, without exposing humans to unnecessary risks, has stimulated the shift of the safety studies to the earliest stages of drug discovery and development. In this regard, in vivo relevant organotypic in vitro models have high potential to revolutionize the preclinical safety testing. They can enable automation of the process, to match the requirements of high-throughput screening approaches, while satisfying ethical considerations. Cultures of primary hepatocytes became already an inherent part of the preclinical pharmaco-toxicological testing battery, yet their routine use, particularly for long-term assays, is limited by the progressive deterioration of liver-specific features. The availability of suitable hepatic and other organ-specific in vitro models is, however, of paramount importance in the light of changing European legal regulations in the field of chemical compounds of different origin, which gradually restrict the use of animal studies for safety assessment, as curr…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00204-012-0983-3

Cites

423 of 423 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 423 references

Research works printed but not linked: 1

  1. Nishimura M, Ejiri Y, Kishimoto S, Suzuki S, Satoh T, Horie T, Narimatsu S, Naito S (2011) Expression levels of drug-metabolizing enzyme, transporter, and nuclear receptor mRNAs in a novel three-dimensional culture system for human hepatocytes using micro-space plates. Drug Metab Pharmacokinet 26(2):137–144 · DOI

Cited by

See all 124

Metadata

Authors
Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M.
Affiliations
Vrije Universiteit Brussel (BE)
Corresponding author
Fraczek, J.
Venue
Archives of Toxicology
Published
2012-12-15
Volume
87
Issue
4
Pages
577-610
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W2018187848
Cited by
119
References
422
Citations by year
2026: 4 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 9 · 2014: 14 · 2013: 5
FWCI
1.63
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Archives of Toxicology (publishedVersion)
  • PubMed (publishedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
primary hepatocyte culture, hepatocyte dedifferentiation, preclinical safety, drug toxicity, high-throughput screening, alternatives to animal testing, long-term hepatocyte culture
MeSH terms
Animals, Animal Testing Alternatives, Cells, Cultured, Drug Evaluation, Preclinical, Humans, Xenobiotics, Apoptosis, Hepatocytes, Mice, Rats, Cell Dedifferentiation, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. https://app.cochat.ai/papers/10.1007/s00204-012-0983-3
The paper
Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M. (2013). Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. Archives of Toxicology. https://doi.org/10.1007/s00204-012-0983-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.